trending Market Intelligence /marketintelligence/en/news-insights/trending/unpsAadZDHQjZRx722z5Ig2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Bausch Health closes $1.5B debt offering, to redeem existing notes

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Bausch Health closes $1.5B debt offering, to redeem existing notes

Bausch Health Cos. Inc. and its indirect unit Bausch Health Americas Inc. closed an offering of senior notes worth about $1.5 billion.

Canada's Bausch Health Cos. issued $500 million of its 5.75% senior secured notes due 2027, and Bausch Health Americas offered $1 billion of its 8.50% senior unsecured notes due 2027.

The drugmaker plans to use the proceeds from the offering to repurchase $1.5 billion worth of its outstanding notes and pay related fees and expenses.

The notes to be redeemed include outstanding 5.625% senior notes due 2021, up to $800 million worth of outstanding 5.50% senior notes due 2023 and 5.875% senior notes due 2023.

As part of the repurchase process, the company issued an irrevocable notice of redemption for any and all outstanding 2021 senior note. Bausch Health expects the after-tax impact of these transactions to be neutral to its 2019 adjusted net income.